Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC, for Production and Sale of Xanthic-Infused Products in Oregon, Nevada and Ohio Cannabis Investing News
Xanthic Biopharma Inc. Closes First Tranche of Oversubscribed Private Placement Cannabis Investing News
Xanthic Biopharma Inc. to Commence Trading on the Canadian Securities Exchange Cannabis Investing News
Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI Pharmaceutical Investing
Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA Biotech Investing
Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for Development of OPNT003 Pharmaceutical Investing
Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy Biotech Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
